Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

BYOOVIZ

SAMSUNG BIOEPIS CO., LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of BYOOVIZ in Canada?

Yes. BYOOVIZ 10MG has an active shortage reported to Health Canada (last updated June 9, 2026).

When will BYOOVIZ be available again?

The manufacturer's estimated resolution date is June 30, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusActive Shortage
Same-ingredient products on file4 products
Expected resolution~9 months remaining (estimate)
Affected strength10MG
Last updated2026-06-09

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

LUCENTIS

NOVARTIS PHARMACEUTICALS CANADA INC

10MG · DIN 02425629

Same strengthSame dosage formSame routeNo current shortage

RANVU

APOTEX INC

10MG · DIN 02568942

Same strengthSame dosage formSame routeNo current shortage

RANOPTO

TEVA CANADA LIMITED

10MG · DIN 02542250

Same strengthSame dosage formSame routeNo current shortage

Other Products

SUSVIMO

HOFFMANN-LA ROCHE LIMITED

100MG · DIN 02530589

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02525852

Strength

10MG

Dosage Form

SOLUTION

Route

INTRAVITREAL

Active Ingredient

RANIBIZUMAB

See all RANIBIZUMAB products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History